Literature DB >> 14500506

Widespread bronchogenic dissemination makes DBA/2 mice more susceptible than C57BL/6 mice to experimental aerosol infection with Mycobacterium tuberculosis.

Pere-Joan Cardona1, Sergi Gordillo, Jorge Díaz, Gustavo Tapia, Isabel Amat, Angeles Pallarés, Cristina Vilaplana, Aurelio Ariza, Vicenç Ausina.   

Abstract

We have used the murine model of aerosol-induced experimental tuberculosis to assess the effects of four clinical isolates and a reference strain of Mycobacterium tuberculosis on resistant C57BL/6 mice and susceptible DBA/2 mice. Histological studies and detection of 25 cytokines potentially involved in the infection were carried out. DBA/2 mice showed higher concentrations of bacilli in bronchoalveolar lavage fluid and lung tissue. Furthermore, these mice evidenced a larger granulomatous infiltration in the parenchyma due to an increased rate of emigration of infected foamy macrophages from the granulomas to the neighboring pulmonary alveolar spaces. The better control of bacillary concentrations and pulmonary infiltration observed in C57BL/6 mice from week 3 postinfection could result from their higher RANTES, ICAM-1, and gamma interferon (IFN-gamma) mRNA levels. On the other hand, the higher MIP-2 and MCP-3 mRNA levels seen in DBA/2 mice would result in stronger lung recruitment of macrophages and neutrophils. Additionally, DBA/2 mice showed increased inducible nitric oxide synthase expression, induced by the larger number of foamy macrophages, at weeks 18 and 22. This increment was a consequence of phagocytosed bacillary debris, was independent of IFN-gamma expression, and could exert only a bacteriostatic effect. The results of the study suggest that DBA/2 mice are more susceptible than C57BL/6 mice to M. tuberculosis infection due to a higher bronchial dissemination of bacilli inside poorly activated foamy macrophages.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500506      PMCID: PMC201050          DOI: 10.1128/IAI.71.10.5845-5854.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

Review 1.  The battle of two genomes: genetics of bacterial host/pathogen interactions in mice.

Authors:  A Lengeling; K Pfeffer; R Balling
Journal:  Mamm Genome       Date:  2001-04       Impact factor: 2.957

2.  Towards a 'human-like' model of tuberculosis: intranasal inoculation of LPS induces intragranulomatous lung necrosis in mice infected aerogenically with Mycobacterium tuberculosis.

Authors:  P J Cardona; R Llatjós; S Gordillo; J Díaz; B Viñado; A Ariza; V Ausina
Journal:  Scand J Immunol       Date:  2001-01       Impact factor: 3.487

3.  Alveolobronchiolar transport mechanisms.

Authors:  G M Green
Journal:  Arch Intern Med       Date:  1973-01

4.  Immunological basis for reactivation of tuberculosis in mice.

Authors:  J Turner; M Gonzalez-Juarrero; B M Saunders; J V Brooks; P Marietta; D L Ellis; A A Frank; A M Cooper; I M Orme
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Genetic control of susceptibility to infection with Mycobacterium tuberculosis in mice.

Authors:  L M Mitsos; L R Cardon; A Fortin; L Ryan; R LaCourse; R J North; P Gros
Journal:  Genes Immun       Date:  2000-12       Impact factor: 2.676

6.  Induction of inducible nitric oxide synthase-NO* by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-kappaB signaling pathways.

Authors:  E D Chan; K R Morris; J T Belisle; P Hill; L K Remigio; P J Brennan; D W Riches
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

7.  Real-time polymerase chain reaction analysis reveals an evolution of cytokine mRNA production in allograft acceptor mice.

Authors:  D Xia; A Sanders; M Shah; A Bickerstaff; C Orosz
Journal:  Transplantation       Date:  2001-09-15       Impact factor: 4.939

8.  Comparative analysis of mycobacterial infections in susceptible I/St and resistant A/Sn inbred mice.

Authors:  B V Nikonenko; M M Averbakh; C Lavebratt; E Schurr; A S Apt
Journal:  Tuber Lung Dis       Date:  2000

9.  Multigenic control of disease severity after virulent Mycobacterium tuberculosis infection in mice.

Authors:  Fabio Sánchez; Tatiana V Radaeva; Boris V Nikonenko; Ann-Sophie Persson; Selim Sengul; Martin Schalling; Erwin Schurr; Alexander S Apt; Catharina Lavebratt
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

10.  Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity.

Authors:  Alissa A Chackerian; Jennifer M Alt; Thushara V Perera; Christopher C Dascher; Samuel M Behar
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

View more
  31 in total

1.  Intragranulomatous necrosis in pulmonary granulomas is not related to resistance against Mycobacterium tuberculosis infection in experimental murine models induced by aerosol.

Authors:  Evelyn Guirado; Sergi Gordillo; Olga Gil; Jorge Díaz; Gustavo Tapia; Cristina Vilaplana; Vicenç Ausina; Pere-Joan Cardona
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

2.  Failure to recruit anti-inflammatory CD103+ dendritic cells and a diminished CD4+ Foxp3+ regulatory T cell pool in mice that display excessive lung inflammation and increased susceptibility to Mycobacterium tuberculosis.

Authors:  Chaniya Leepiyasakulchai; Lech Ignatowicz; Andrzej Pawlowski; Gunilla Källenius; Markus Sköld
Journal:  Infect Immun       Date:  2012-01-03       Impact factor: 3.441

3.  A hybrid multi-compartment model of granuloma formation and T cell priming in tuberculosis.

Authors:  Simeone Marino; Mohammed El-Kebir; Denise Kirschner
Journal:  J Theor Biol       Date:  2011-04-01       Impact factor: 2.691

4.  Trehalose 6,6'-dimycolate and lipid in the pathogenesis of caseating granulomas of tuberculosis in mice.

Authors:  Robert L Hunter; Margaret Olsen; Chinnaswamy Jagannath; Jeffrey K Actor
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

5.  Genetic susceptibility to toxicologic lung responses among inbred mouse strains following exposure to carbon nanotubes and profiling of underlying gene networks.

Authors:  Evan A Frank; Vinicius S Carreira; Kumar Shanmukhappa; Mario Medvedovic; Daniel R Prows; Jagjit S Yadav
Journal:  Toxicol Appl Pharmacol       Date:  2017-04-19       Impact factor: 4.219

6.  Several classical mouse inbred strains, including DBA/2, NOD/Lt, FVB/N, and SJL/J, carry a putative loss-of-function allele of Gpr84.

Authors:  Carlos J Perez; Aline Dumas; Luc Vallières; Jean-Louis Guénet; Fernando Benavides
Journal:  J Hered       Date:  2013-04-24       Impact factor: 2.645

7.  Granuloma encapsulation is a key factor for containing tuberculosis infection in minipigs.

Authors:  Olga Gil; Ivan Díaz; Cristina Vilaplana; Gustavo Tapia; Jorge Díaz; María Fort; Neus Cáceres; Sergio Pinto; Joan Caylà; Leigh Corner; Mariano Domingo; Pere-Joan Cardona
Journal:  PLoS One       Date:  2010-04-06       Impact factor: 3.240

8.  In mice, tuberculosis progression is associated with intensive inflammatory response and the accumulation of Gr-1 cells in the lungs.

Authors:  Irina V Lyadova; Evgeny N Tsiganov; Marina A Kapina; Galena S Shepelkova; Vasily V Sosunov; Tatiana V Radaeva; Konstantin B Majorov; Natalya S Shmitova; Henk-Jan van den Ham; Vitaly V Ganusov; Rob J De Boer; Rachael Racine; Gary M Winslow
Journal:  PLoS One       Date:  2010-05-04       Impact factor: 3.240

Review 9.  Foamy macrophages and the progression of the human tuberculosis granuloma.

Authors:  David G Russell; Pere-Joan Cardona; Mi-Jeong Kim; Sophie Allain; Frédéric Altare
Journal:  Nat Immunol       Date:  2009-08-19       Impact factor: 25.606

10.  Induction of a specific strong polyantigenic cellular immune response after short-term chemotherapy controls bacillary reactivation in murine and guinea pig experimental models of tuberculosis.

Authors:  Evelyn Guirado; Olga Gil; Neus Cáceres; Mahavir Singh; Cristina Vilaplana; Pere-Joan Cardona
Journal:  Clin Vaccine Immunol       Date:  2008-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.